Evolution of the Average Target: MakeMyTrip Limited

Evolution of the Target Price: MakeMyTrip Limited

Changes in Analyst Recommendations: MakeMyTrip Limited

79fc78b46.aKK9E35YJh2_0VaRSzOpciadw-Fi0b_xZ1g1Ki_VCBI.J_uJJg0abDCNiTTUKGDOHlyop9I7t8W9JWhifF6yXXkA5stlDRZqadSmZg~94c01d6c823a13225a847b70166e4940
03-30 Morpheus Research says it holds short positions in MakeMyTrip RE
01-22 Morgan Stanley Trims Price Target on MakeMyTrip to $106 From $113, Keeps Overweight Rating MT
01-21 Citigroup Lowers MakeMyTrip's Price Target to $96 from $108, Keeps Buy Rating MT
11-17 CICC Initiates MakeMyTrip at Outperform With $95 Price Target MT
24/06/25 Macquarie Upgrades MakeMyTrip to Outperform From Neutral, $110 Price Target MT
21/02/24 Macquarie Downgrades MakeMyTrip to Neutral From Outperform, Adjusts Price Target to $60 From $50 MT
21/02/24 Macquarie Downgrades MakeMyTrip to Neutral From Outperform, Raises Price Target to $60 From $50 MT
26/12/23 Citigroup Raises Price Target on MakeMyTrip to $54 From $47, Maintains Buy Rating MT
02/08/23 Citigroup Adjusts Price Target on MakeMyTrip to $45 From $43, Maintains Buy Rating MT
08/12/22 Morgan Stanley Upgrades MakeMyTrip to Overweight From Equalweight, Price Target is $36 MT
04/10/22 UBS Adjusts MakeMyTrip Price Target to $40 From $37, Maintains Buy Rating MT
14/09/22 JPMorgan Starts MakeMyTrip at Overweight With $44 Price Target MT
31/08/22 Macquarie Starts MakeMyTrip at Outperform With $42 Price Target MT
30/08/22 BofA Securities Upgrades MakeMyTrip to Buy from Neutral, Adjusts Price Target to $40 from $33 MT
13/06/22 UBS Double Upgrades MakeMyTrip to Buy From Sell on a Recovering Travel Market, Adjusts Price Target to $37 From $23 MT
26/05/22 Goldman Sachs Lifts Price Target for MakeMyTrip to $39 From $38, Maintains Buy Rating MT
26/05/22 Citigroup Adjusts MakeMyTrip's Price Target to $43 from $42, Keeps Buy Rating MT
24/02/22 Morgan Stanley Resumes Coverage of MakeMyTrip With Overweight Rating, $29 Price Target MT
28/07/21 MakeMyTrip : Citigroup Adjusts Price Target on MakeMyTrip to $38 From $34, Reiterates Buy Rating MT
01/06/21 MakeMyTrip : Ambit Capital Initiates Coverage on MakeMyTrip With Buy Rating, $37 Price Target MT
16/02/21 MakeMyTrip : BofA Securities Upgrades MakeMyTrip to Neutral From Underperform, Adjusts Price Target to $32 From $14 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+57.54%
+39.31%
+18.07%
+44.15%
+14.94%
+29.13%
+16.11%
+55.11%
- - +0.56%
+70.89%
Average +34.58%
Weighted average by Cap. +36.27%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
47.86USD
Average target price
75.40USD
Spread / Average Target
+57.54%
High Price Target
85.00USD
Spread / Highest target
+77.60%
Low Price Target
65.00USD
Spread / Lowest Target
+35.81%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
-
  1. Stock Market
  2. Stocks
  3. MMYT Stock
  4. Consensus MakeMyTrip Limited
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!